Whereas triple-negative breast cancer was recognized as a distinct type of cancer in 2006;

Whereas triple-negative breast cancer disproportionately affects young women, Black and Hispanic women, and those with BRCA gene mutations;

Whereas triple-negative breast cancers are estrogen receptor-negative, progesterone receptor-negative, and HER2-negative, making them distinct from other breast cancers;

Whereas 10 to 15 percent of all breast cancer diagnoses are designated as triple-negative;

Whereas triple-negative breast cancer can be more aggressive and more likely to spread and recur;

Whereas triple-negative breast cancer accounts for around 25 percent of all deaths from breast cancer in the United States; and

Whereas March 3, 2025, would be an appropriate date to designate as National Triple-Negative Breast Cancer Day: Now, therefore, be it